(Q51484828)

English

Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people.

scientific article published on 28 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

0 references

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

quantitative trait

1 reference

based on heuristic

inferred from title

metabolic trait

1 reference

based on heuristic

inferred from title

Torben Jørgensen

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

object named as

Torben Hansen

7

0 references

Oluf Borbye Pedersen

object named as

Oluf Pedersen

8

0 references

author name string

Thomas Sparsø

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Meena S Hussain

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Gitte Andersen

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Irena Hainerova

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Knut Borch-Johnsen

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

publication date

28 November 2006

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

90

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

205-209

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Recent update on the PPAR alpha-null mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Phylogeny of the steroid receptor superfamily.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.10.007

7 January 2021

Identifiers

10.1016/J.YMGME.2006.10.007

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/17129741

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51484828&oldid=1786262833"